EDGAR Filing Documents for 0001193125-13-443078

Form 8-K - Current report:

SEC Accession No. 0001193125-13-443078

Filing Date

2013-11-15

Accepted

2013-11-15 07:39:59

Documents

Period of Report

2013-11-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d630932d8k.htm	8-K	33158
2	EX-3.1	d630932dex31.htm	EX-3.1	78079
3	EX-4.1	d630932dex41.htm	EX-4.1	8629
4	EX-10.1	d630932dex101.htm	EX-10.1	59531
5	EX-99.1	d630932dex991.htm	EX-99.1	12311
6	GRAPHIC	g630932001.jpg	GRAPHIC	6221
7	GRAPHIC	g630932002.jpg	GRAPHIC	5949
	Complete submission text file	0001193125-13-443078.txt		210083

Mailing Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121

Business Address 3101 WESTERN AVENUE SUITE 600 SEATTLE WA 98121 2062827100

CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)